The Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.

by Cancer Today Staff

Judicial threats to the Affordable Care Act continue, and a study investigates the long-term risks of chemotherapy.

by Kate Yandell and Marci A. Landsmann

Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.

by Bob Riter

High-intensity cancer caregiving is associated with poor mental health, especially for caregivers who don't feel they're getting the support services they need.

by Jen Tota McGivney

A long-term trial presents new evidence on who should have surgery for localized prostate cancer, and a review finds that women are temporarily at increased risk of breast cancer after giving birth.

by Kate Yandell

Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.

by Kate Yandell

A trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.

by Kate Yandell

A study warns that popular YouTube videos about prostate cancer may be misleading, and the U.S. Food and Drug Administration approves a therapy based on tumor genetics, not tumor origin.

by Kate Yandell

Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.

by Anna Azvolinsky

Patients with head and neck cancer often face physical, social and emotional issues that can add to existing mental health problems or give rise to new ones.

by Cheryl Platzman Weinstock